Insider Selling: Genpact Limited (NYSE:G) CEO Sells 70,000 Shares of Stock

Share on StockTwits

Genpact Limited (NYSE:G) CEO N. V. Tyagarajan sold 70,000 shares of the company’s stock in a transaction on Friday, April 16th. The stock was sold at an average price of $45.01, for a total value of $3,150,700.00. Following the sale, the chief executive officer now owns 693,765 shares of the company’s stock, valued at $31,226,362.65. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Genpact stock opened at $44.52 on Tuesday. The company has a market capitalization of $8.33 billion, a PE ratio of 27.65, a PEG ratio of 2.13 and a beta of 1.32. Genpact Limited has a 12-month low of $29.42 and a 12-month high of $45.21. The firm’s fifty day moving average is $43.16 and its 200 day moving average is $40.86. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.74.

Genpact (NYSE:G) last issued its earnings results on Monday, February 8th. The business services provider reported $0.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.02. The company had revenue of $950.57 million during the quarter, compared to the consensus estimate of $933.93 million. Genpact had a return on equity of 21.81% and a net margin of 8.53%. Sell-side analysts expect that Genpact Limited will post 1.8 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 19th. Shareholders of record on Wednesday, March 10th were paid a dividend of $0.108 per share. This represents a $0.43 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date was Tuesday, March 9th. This is a positive change from Genpact’s previous quarterly dividend of $0.10. Genpact’s payout ratio is 27.56%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bessemer Group Inc. lifted its holdings in Genpact by 953.0% during the fourth quarter. Bessemer Group Inc. now owns 874 shares of the business services provider’s stock worth $36,000 after acquiring an additional 791 shares during the period. Perigon Wealth Management LLC purchased a new stake in Genpact in the 4th quarter worth about $48,000. Huntington National Bank raised its stake in Genpact by 42.5% in the 4th quarter. Huntington National Bank now owns 1,486 shares of the business services provider’s stock valued at $61,000 after acquiring an additional 443 shares during the period. Neo Ivy Capital Management lifted its holdings in Genpact by 268.7% during the fourth quarter. Neo Ivy Capital Management now owns 2,190 shares of the business services provider’s stock valued at $91,000 after purchasing an additional 1,596 shares during the last quarter. Finally, Nisa Investment Advisors LLC boosted its position in Genpact by 20.4% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,770 shares of the business services provider’s stock worth $115,000 after purchasing an additional 470 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

A number of equities research analysts have recently weighed in on G shares. Zacks Investment Research downgraded shares of Genpact from a “buy” rating to a “hold” rating and set a $42.00 price target on the stock. in a research note on Tuesday, February 2nd. Needham & Company LLC increased their price target on Genpact from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Wednesday, February 10th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Genpact currently has a consensus rating of “Buy” and an average price target of $42.88.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.

Further Reading: Trading Halts

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with's FREE daily email newsletter.